February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...

AbbVie is a resurging Dividend King. Amgen's recent clinical setback makes its stock available at a discount. Gilead Sciences is a steady dividend payer with a growing payout. For a while, though ...

Amgen's shares fell late last year after it released phase 2 data for its weight loss candidate, MariTide. Though the stock has rebounded somewhat, it's still down over the past year. MariTide's ...

That brings us to Amgen. In November, it reported mid-stage clinical trial results for MariTide, an investigational weight loss treatment, and the market responded by sending the stock down more ...